Relay Therapeutics, Inc. RLAY Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s operating cash flow?
- Relay Therapeutics, Inc. (RLAY) reported operating cash flow of -$51.11M in Q1 2026.
- How has Relay Therapeutics, Inc.'s operating cash flow changed year-over-year?
- Relay Therapeutics, Inc.'s operating cash flow increased by 30.2% year-over-year, from -$73.21M to -$51.11M.
- What is the long-term trend for Relay Therapeutics, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s operating cash flow has grown at a 33.4% compound annual growth rate (CAGR), from -$74.41M to -$235.46M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.